NCT01299220View on ClinicalTrials.gov

Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug)

PHASE4WithdrawnINTERVENTIONAL

0

Timeline

Start Date

November 30, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions

Skin Rash

Interventions

DRUG

Acitretin

Acitretin 10 mg by mouth daily

Trial Locations (1)

15213

University of Pittsburgh Medical Center, Pittsburgh

Sponsors

Collaborators (1)

OSI Pharmaceuticals

All Listed Sponsors

collaborator

OSI Pharmaceuticals

INDUSTRY

lead

University of Pittsburgh

OTHER